Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infection.
Streptococcus pyogenes (group A Streptococcus; GAS) causes clinical diseases, including pharyngitis, scarlet fever, impetigo, necrotizing fasciitis and streptococcal toxic shock syndrome. A number of group A streptococcus vaccine candidates have been developed, but only one 26-valent recombinant M p...
Main Authors: | Chih-Feng Kuo, Nina Tsao, I-Chen Hsieh, Yee-Shin Lin, Jiunn-Jong Wu, Yu-Ting Hung |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5371370?pdf=render |
Similar Items
-
Application of the C3-binding motif of streptococcal pyrogenic exotoxin B to protect mice from invasive group a streptococcal infection.
by: Chih-Feng Kuo, et al.
Published: (2015-01-01) -
Determining antibody-binding site of streptococcal pyrogenic exotoxin B to protect mice from group a streptococcus infection.
by: Nina Tsao, et al.
Published: (2013-01-01) -
Contribution of cryptic epitopes in designing a group A streptococcal vaccine
by: Victoria Ozberk, et al.
Published: (2018-08-01) -
Invasive Group A Streptococcal Disease: Management and Chemoprophylaxis
by: UD Allen, et al.
Published: (2010-01-01) -
Fulminant invasive group A streptococcal infection in children
by: S. B. Yatsyshina, et al.
Published: (2023-12-01)